Financials
- Market Capitalization 22.99 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
13.29
売上高対価格比率
3.54
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 520 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.30 USD | +1.13% | -3.55% | +3.72% | +51.10% | 25.03 B USD | ||
| 534 | INSM Insmed Incorporated - Common Stock | 109.78 USD | -0.30% | -5.79% | +12.59% | -32.26% | 23.80 B USD | ||
| 556 | UTHR United Therapeutics Corporation - Common Stock | 532.09 USD | +1.03% | -4.01% | -3.86% | +80.22% | 22.59 B USD | ||
| 569 | BNTX BioNTech SE - American Depositary Shares | 91.93 USD | +1.69% | -1.71% | +1.32% | -16.50% | 22.06 B USD |